Award
NIH Reporter #5P30CA014520-52
Drug Development Core
Recipient
University of Wisconsin–Madison
Award Amount
$102,910.00
Ceiling
$102,910.00
Awarded
September 17, 2026
Identifier
5P30CA014520-52
The National Cancer Institute awarded funding to the University of Wisconsin–Madison for its Drug Development Core. The core provides drug-discovery and optimization services, supports clinical-trial drug analysis, and trains researchers and staff.
Description
Funding for the Drug Development Core, which supports UWCCC research and clinical trials through drug screening, medicinal chemistry, lead optimization, pharmacokinetic and pharmacodynamic services, and training.